期刊文献+

荧光原位杂交在子宫颈病变的癌变风险预测中的应用 被引量:2

Application of Fluorescence in Situ Hybridisation into Forecasting Canceration Risk of Cervix Disease
下载PDF
导出
摘要 目的探讨hTERC基因在不同宫颈病变中的扩增情况及hTERC基因扩增对宫颈病变发展趋势的预测意义。方法利用FISH在荧光显微镜下观察3号染色体着丝粒CSP3和hTERC基因双色探针的杂交效果,检测不同宫颈病变中hTERC基因扩增情况,对部分存在hTERC基因扩增的患者进行随访。结果随着宫颈病变的发展,hTERC基因扩增的阳性率及扩增的细胞所占比例均在不断升高,差异具有统计学意义。结论 hTERC基因扩增与宫颈病变的发展密切相关,FISH检测hTERC基因是否存在扩增可能成为预测宫颈病变发展趋势的可靠手段。 Objective To explore the circumstance of hTERC gene amplification in the differ cervix disease and the forecasting significance between hTERC gene amplification and developmental tendency of cervix.Methods Using fluorescence microscope to observe the crossing effection of centromeric probe for 3 chromosome and the probe of hTERC gene.The circumstance of hTERC gene amplification is detected in the differ cervix disease.Meanwhile,the cases which have hTERC gene amplification are followed up.Results Amplification of hTERC gene is enhanced along with the development of cervix disease which has statistical significance.Conclusion There is close correlation between the hTERC gene amplification and the development of cervix disease,Using FISH to detect hTERC gene amplification may be the dependable means to forecast the developmental tendency of cervix disease.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2011年第4期420-422,共3页 Cancer Research on Prevention and Treatment
基金 湖北省卫生厅科研一般项目资助课题(JX4B71)
关键词 荧光原位杂交 宫颈上皮内病变 HTERC基因 Fluorescence in situ hybridisation Cervical intraepithelial neoplasia hTERC gene
  • 相关文献

参考文献5

  • 1吕亚莉,钟梅,赵坡.应用荧光原位杂交法检测乳腺癌石腊样本中HER-2基因的扩增[J].肿瘤防治研究,2007,34(5):345-347. 被引量:19
  • 2Tsezou A,Oikonomou P,Kollia P,et al.The role of human telomerase catalytic subunit mRNA expression in cervical dysplasias [J].Exp Biol Med,2005,230(4):263-270.
  • 3Heselmeyer-Haddad K,Janz V,Castle PE, et al.Detection of genomic amplification of the human telomerase gene (TERC) in cytologic specimens as a genetic test for the diagnosisof cervical dysplasia[J].Am J Pathol, 2003,163(4): 1405-1416.
  • 4Huang FY, Kwok YK, Lau ET, et al.Genetic abnormalities and HPV status in cervical and vulvar squamous cell carcinomas[J].Cancer Genet Cytogenet,2005,157(1):42-48.
  • 5Caraway NP,Khanna A,Dawlett M,et al.Gain of the 3q26 region in cervicovaginal liquid- based pap preparations is associated with squamous intraepithelial lesions and squamous cell carcinoma[J].Gynecol Oncol,2008,110(1):37-42.

二级参考文献8

  • 1Bozionellou V,Mavroudis D,Perraki M,et al.Trastuzumab administration can effectively target chemotherapy-resistant cytokeratin-19 messenger RNA-positive tumor cells in the peripheral blood and bone and bone marrow of patients with breast cancer[J].Clin Cancer Res,2004,10(24):8185-8194.
  • 2Bozzetti C,Nizzoli R,Guazzi A,et al.HER-2/neu amplification detected by fluorescence in situ hybridization in fine needle aspirates from primary breast cancer[J].Ann Oncol,2002,13(9):1398-1403.
  • 3Press MF,Sauter G,Bernstein L,et al.Diagnostic evaluation of HER-2 as a molecular target:an assessment of accuracy and reproducibility of laboratory testing in large,prospective,randomized clinical trials[J].Clin Cancer Res,2005,11(18):6598-6607.
  • 4Vogel CL,Reddy JC,Reyno LM.Efficacy of trastuzumab[J].Cancer Res,2005,65(5):2044.
  • 5Slamon DJ,Romond EH,Perez EA.Advances in adjuvant therapy for breast cancer[J].Clin Adv Hematol Oncol,2006,4(3):suppl 1,4-9.
  • 6Nabhohtz JM,Slamon n New adjuvant strategies for breast cancer:meeting the challenge of integrating chemotherapy and trastuzumab (Herceptin)[J].Semin Oncol,2001,28(1 Suppl 3):1-12.
  • 7Lan C,Liu JM,Liu TW,et al.erbB2 amplification by fluorescence in situ hybridization in breast cancer specimens read as 2+ in immunohistochemical analysis[J].Am J Clin Pathol,2005,124(1):97-102.
  • 8Dolan M,Snover D.Comparison of immunohistochemical and fluorescence in situ hybridization assessment of HER-2 status in routine practice[J].Am J Clin Pathol,2005,123(5):766-770.

共引文献18

同被引文献19

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部